Inhibitory Effects of Quercetin and Its Human and Microbial Metabolites on Xanthine Oxidase Enzyme
Quercetin is an abundant flavonoid in nature and is used in several dietary supplements. Although quercetin is extensively metabolized by human enzymes and the colonic microflora, we have only few data regarding the pharmacokinetic interactions of its metabolites. Therefore, we investigated the inte...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2019-05, Vol.20 (11), p.2681 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 11 |
container_start_page | 2681 |
container_title | International journal of molecular sciences |
container_volume | 20 |
creator | Mohos, Violetta Pánovics, Attila Fliszár-Nyúl, Eszter Schilli, Gabriella Hetényi, Csaba Mladěnka, Přemysl Needs, Paul W Kroon, Paul A Pethő, Gábor Poór, Miklós |
description | Quercetin is an abundant flavonoid in nature and is used in several dietary supplements. Although quercetin is extensively metabolized by human enzymes and the colonic microflora, we have only few data regarding the pharmacokinetic interactions of its metabolites. Therefore, we investigated the interaction of human and microbial metabolites of quercetin with the xanthine oxidase enzyme. Inhibitory effects of five conjugates and 23 microbial metabolites were examined with 6-mercaptopurine and xanthine substrates (both at 5 μM), employing allopurinol as a positive control. Quercetin-3'-sulfate, isorhamnetin, tamarixetin, and pyrogallol proved to be strong inhibitors of xanthine oxidase. Sulfate and methyl conjugates were similarly strong inhibitors of both 6-mercaptopurine and xanthine oxidations (IC
= 0.2-0.7 μM); however, pyrogallol inhibited xanthine oxidation (IC
= 1.8 μM) with higher potency vs. 6-MP oxidation (IC
= 10.1 μM). Sulfate and methyl conjugates were approximately ten-fold stronger inhibitors (IC
= 0.2-0.6 μM) of 6-mercaptopurine oxidation than allopurinol (IC
= 7.0 μM), and induced more potent inhibition compared to quercetin (IC
= 1.4 μM). These observations highlight that some quercetin metabolites can exert similar or even a stronger inhibitory effect on xanthine oxidase than the parent compound, which may lead to the development of quercetin-drug interactions (e.g., with 6-mercaptopurin or azathioprine). |
doi_str_mv | 10.3390/ijms20112681 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6600370</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2235071069</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-5f2fcb3becd3c4bf7259133ebb5b30f7b2a92c49ae2cdcbb51ef711557ce6d8b3</originalsourceid><addsrcrecordid>eNpdkUtrWzEQhUVJyHvXdRBkk0Wd6HEf1qZQgtsYEkwghe6EpDuKZe6VUkm3xP31UbAb3Kw0mvl0mKOD0GdKrjgX5NqthsQIpayZ0k_oiFaMTQhp2r2d-hAdp7QihHFWiwN0yCmtBa3pEdJzv3Ta5RDXeGYtmJxwsPhhhGggO4-V7_C8NG_HQW1u987EoJ3q8T1kpUPvMpRHHv9SPi-dB7x4cZ1KgGf-73qAU7RvVZ_gbHueoJ_fZ483t5O7xY_5zbe7ianaaZ7UllmjuQbTcVNp25ZVKeegda05sa1mSjBTCQXMdKZ0Kdi2-KhbA0031fwEfd3oPo96gM6Az1H18jm6QcW1DMrJ_yfeLeVT-CObhhDekiJwuRWI4fcIKcvBJQN9rzyEMUnGeE1aShpR0IsP6CqM0Rd7haqEqCoqWKG-bKjyYSlFsO_LUCLfwpO74RX8fNfAO_wvLf4K3c2XaQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2249944192</pqid></control><display><type>article</type><title>Inhibitory Effects of Quercetin and Its Human and Microbial Metabolites on Xanthine Oxidase Enzyme</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Mohos, Violetta ; Pánovics, Attila ; Fliszár-Nyúl, Eszter ; Schilli, Gabriella ; Hetényi, Csaba ; Mladěnka, Přemysl ; Needs, Paul W ; Kroon, Paul A ; Pethő, Gábor ; Poór, Miklós</creator><creatorcontrib>Mohos, Violetta ; Pánovics, Attila ; Fliszár-Nyúl, Eszter ; Schilli, Gabriella ; Hetényi, Csaba ; Mladěnka, Přemysl ; Needs, Paul W ; Kroon, Paul A ; Pethő, Gábor ; Poór, Miklós</creatorcontrib><description>Quercetin is an abundant flavonoid in nature and is used in several dietary supplements. Although quercetin is extensively metabolized by human enzymes and the colonic microflora, we have only few data regarding the pharmacokinetic interactions of its metabolites. Therefore, we investigated the interaction of human and microbial metabolites of quercetin with the xanthine oxidase enzyme. Inhibitory effects of five conjugates and 23 microbial metabolites were examined with 6-mercaptopurine and xanthine substrates (both at 5 μM), employing allopurinol as a positive control. Quercetin-3'-sulfate, isorhamnetin, tamarixetin, and pyrogallol proved to be strong inhibitors of xanthine oxidase. Sulfate and methyl conjugates were similarly strong inhibitors of both 6-mercaptopurine and xanthine oxidations (IC
= 0.2-0.7 μM); however, pyrogallol inhibited xanthine oxidation (IC
= 1.8 μM) with higher potency vs. 6-MP oxidation (IC
= 10.1 μM). Sulfate and methyl conjugates were approximately ten-fold stronger inhibitors (IC
= 0.2-0.6 μM) of 6-mercaptopurine oxidation than allopurinol (IC
= 7.0 μM), and induced more potent inhibition compared to quercetin (IC
= 1.4 μM). These observations highlight that some quercetin metabolites can exert similar or even a stronger inhibitory effect on xanthine oxidase than the parent compound, which may lead to the development of quercetin-drug interactions (e.g., with 6-mercaptopurin or azathioprine).</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms20112681</identifier><identifier>PMID: 31159151</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>6-Mercaptopurine ; Allopurinol ; Azathioprine ; Chromatography ; Conjugates ; Dietary supplements ; Enzymes ; Flavonoids ; Granulocytes ; Inhibitors ; Metabolites ; Microflora ; Microorganisms ; Oxidation ; Pharmacology ; Pharmacy ; Quercetin ; Research parks ; Sulfates ; Uric acid ; Xanthine oxidase</subject><ispartof>International journal of molecular sciences, 2019-05, Vol.20 (11), p.2681</ispartof><rights>2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 by the authors. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-5f2fcb3becd3c4bf7259133ebb5b30f7b2a92c49ae2cdcbb51ef711557ce6d8b3</citedby><cites>FETCH-LOGICAL-c478t-5f2fcb3becd3c4bf7259133ebb5b30f7b2a92c49ae2cdcbb51ef711557ce6d8b3</cites><orcidid>0000-0002-8013-971X ; 0000-0002-6076-6900 ; 0000-0002-9805-6947</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600370/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600370/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31159151$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohos, Violetta</creatorcontrib><creatorcontrib>Pánovics, Attila</creatorcontrib><creatorcontrib>Fliszár-Nyúl, Eszter</creatorcontrib><creatorcontrib>Schilli, Gabriella</creatorcontrib><creatorcontrib>Hetényi, Csaba</creatorcontrib><creatorcontrib>Mladěnka, Přemysl</creatorcontrib><creatorcontrib>Needs, Paul W</creatorcontrib><creatorcontrib>Kroon, Paul A</creatorcontrib><creatorcontrib>Pethő, Gábor</creatorcontrib><creatorcontrib>Poór, Miklós</creatorcontrib><title>Inhibitory Effects of Quercetin and Its Human and Microbial Metabolites on Xanthine Oxidase Enzyme</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Quercetin is an abundant flavonoid in nature and is used in several dietary supplements. Although quercetin is extensively metabolized by human enzymes and the colonic microflora, we have only few data regarding the pharmacokinetic interactions of its metabolites. Therefore, we investigated the interaction of human and microbial metabolites of quercetin with the xanthine oxidase enzyme. Inhibitory effects of five conjugates and 23 microbial metabolites were examined with 6-mercaptopurine and xanthine substrates (both at 5 μM), employing allopurinol as a positive control. Quercetin-3'-sulfate, isorhamnetin, tamarixetin, and pyrogallol proved to be strong inhibitors of xanthine oxidase. Sulfate and methyl conjugates were similarly strong inhibitors of both 6-mercaptopurine and xanthine oxidations (IC
= 0.2-0.7 μM); however, pyrogallol inhibited xanthine oxidation (IC
= 1.8 μM) with higher potency vs. 6-MP oxidation (IC
= 10.1 μM). Sulfate and methyl conjugates were approximately ten-fold stronger inhibitors (IC
= 0.2-0.6 μM) of 6-mercaptopurine oxidation than allopurinol (IC
= 7.0 μM), and induced more potent inhibition compared to quercetin (IC
= 1.4 μM). These observations highlight that some quercetin metabolites can exert similar or even a stronger inhibitory effect on xanthine oxidase than the parent compound, which may lead to the development of quercetin-drug interactions (e.g., with 6-mercaptopurin or azathioprine).</description><subject>6-Mercaptopurine</subject><subject>Allopurinol</subject><subject>Azathioprine</subject><subject>Chromatography</subject><subject>Conjugates</subject><subject>Dietary supplements</subject><subject>Enzymes</subject><subject>Flavonoids</subject><subject>Granulocytes</subject><subject>Inhibitors</subject><subject>Metabolites</subject><subject>Microflora</subject><subject>Microorganisms</subject><subject>Oxidation</subject><subject>Pharmacology</subject><subject>Pharmacy</subject><subject>Quercetin</subject><subject>Research parks</subject><subject>Sulfates</subject><subject>Uric acid</subject><subject>Xanthine oxidase</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkUtrWzEQhUVJyHvXdRBkk0Wd6HEf1qZQgtsYEkwghe6EpDuKZe6VUkm3xP31UbAb3Kw0mvl0mKOD0GdKrjgX5NqthsQIpayZ0k_oiFaMTQhp2r2d-hAdp7QihHFWiwN0yCmtBa3pEdJzv3Ta5RDXeGYtmJxwsPhhhGggO4-V7_C8NG_HQW1u987EoJ3q8T1kpUPvMpRHHv9SPi-dB7x4cZ1KgGf-73qAU7RvVZ_gbHueoJ_fZ483t5O7xY_5zbe7ianaaZ7UllmjuQbTcVNp25ZVKeegda05sa1mSjBTCQXMdKZ0Kdi2-KhbA0031fwEfd3oPo96gM6Az1H18jm6QcW1DMrJ_yfeLeVT-CObhhDekiJwuRWI4fcIKcvBJQN9rzyEMUnGeE1aShpR0IsP6CqM0Rd7haqEqCoqWKG-bKjyYSlFsO_LUCLfwpO74RX8fNfAO_wvLf4K3c2XaQ</recordid><startdate>20190531</startdate><enddate>20190531</enddate><creator>Mohos, Violetta</creator><creator>Pánovics, Attila</creator><creator>Fliszár-Nyúl, Eszter</creator><creator>Schilli, Gabriella</creator><creator>Hetényi, Csaba</creator><creator>Mladěnka, Přemysl</creator><creator>Needs, Paul W</creator><creator>Kroon, Paul A</creator><creator>Pethő, Gábor</creator><creator>Poór, Miklós</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8013-971X</orcidid><orcidid>https://orcid.org/0000-0002-6076-6900</orcidid><orcidid>https://orcid.org/0000-0002-9805-6947</orcidid></search><sort><creationdate>20190531</creationdate><title>Inhibitory Effects of Quercetin and Its Human and Microbial Metabolites on Xanthine Oxidase Enzyme</title><author>Mohos, Violetta ; Pánovics, Attila ; Fliszár-Nyúl, Eszter ; Schilli, Gabriella ; Hetényi, Csaba ; Mladěnka, Přemysl ; Needs, Paul W ; Kroon, Paul A ; Pethő, Gábor ; Poór, Miklós</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-5f2fcb3becd3c4bf7259133ebb5b30f7b2a92c49ae2cdcbb51ef711557ce6d8b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>6-Mercaptopurine</topic><topic>Allopurinol</topic><topic>Azathioprine</topic><topic>Chromatography</topic><topic>Conjugates</topic><topic>Dietary supplements</topic><topic>Enzymes</topic><topic>Flavonoids</topic><topic>Granulocytes</topic><topic>Inhibitors</topic><topic>Metabolites</topic><topic>Microflora</topic><topic>Microorganisms</topic><topic>Oxidation</topic><topic>Pharmacology</topic><topic>Pharmacy</topic><topic>Quercetin</topic><topic>Research parks</topic><topic>Sulfates</topic><topic>Uric acid</topic><topic>Xanthine oxidase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohos, Violetta</creatorcontrib><creatorcontrib>Pánovics, Attila</creatorcontrib><creatorcontrib>Fliszár-Nyúl, Eszter</creatorcontrib><creatorcontrib>Schilli, Gabriella</creatorcontrib><creatorcontrib>Hetényi, Csaba</creatorcontrib><creatorcontrib>Mladěnka, Přemysl</creatorcontrib><creatorcontrib>Needs, Paul W</creatorcontrib><creatorcontrib>Kroon, Paul A</creatorcontrib><creatorcontrib>Pethő, Gábor</creatorcontrib><creatorcontrib>Poór, Miklós</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohos, Violetta</au><au>Pánovics, Attila</au><au>Fliszár-Nyúl, Eszter</au><au>Schilli, Gabriella</au><au>Hetényi, Csaba</au><au>Mladěnka, Přemysl</au><au>Needs, Paul W</au><au>Kroon, Paul A</au><au>Pethő, Gábor</au><au>Poór, Miklós</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitory Effects of Quercetin and Its Human and Microbial Metabolites on Xanthine Oxidase Enzyme</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2019-05-31</date><risdate>2019</risdate><volume>20</volume><issue>11</issue><spage>2681</spage><pages>2681-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Quercetin is an abundant flavonoid in nature and is used in several dietary supplements. Although quercetin is extensively metabolized by human enzymes and the colonic microflora, we have only few data regarding the pharmacokinetic interactions of its metabolites. Therefore, we investigated the interaction of human and microbial metabolites of quercetin with the xanthine oxidase enzyme. Inhibitory effects of five conjugates and 23 microbial metabolites were examined with 6-mercaptopurine and xanthine substrates (both at 5 μM), employing allopurinol as a positive control. Quercetin-3'-sulfate, isorhamnetin, tamarixetin, and pyrogallol proved to be strong inhibitors of xanthine oxidase. Sulfate and methyl conjugates were similarly strong inhibitors of both 6-mercaptopurine and xanthine oxidations (IC
= 0.2-0.7 μM); however, pyrogallol inhibited xanthine oxidation (IC
= 1.8 μM) with higher potency vs. 6-MP oxidation (IC
= 10.1 μM). Sulfate and methyl conjugates were approximately ten-fold stronger inhibitors (IC
= 0.2-0.6 μM) of 6-mercaptopurine oxidation than allopurinol (IC
= 7.0 μM), and induced more potent inhibition compared to quercetin (IC
= 1.4 μM). These observations highlight that some quercetin metabolites can exert similar or even a stronger inhibitory effect on xanthine oxidase than the parent compound, which may lead to the development of quercetin-drug interactions (e.g., with 6-mercaptopurin or azathioprine).</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>31159151</pmid><doi>10.3390/ijms20112681</doi><orcidid>https://orcid.org/0000-0002-8013-971X</orcidid><orcidid>https://orcid.org/0000-0002-6076-6900</orcidid><orcidid>https://orcid.org/0000-0002-9805-6947</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2019-05, Vol.20 (11), p.2681 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6600370 |
source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | 6-Mercaptopurine Allopurinol Azathioprine Chromatography Conjugates Dietary supplements Enzymes Flavonoids Granulocytes Inhibitors Metabolites Microflora Microorganisms Oxidation Pharmacology Pharmacy Quercetin Research parks Sulfates Uric acid Xanthine oxidase |
title | Inhibitory Effects of Quercetin and Its Human and Microbial Metabolites on Xanthine Oxidase Enzyme |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T12%3A43%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitory%20Effects%20of%20Quercetin%20and%20Its%20Human%20and%20Microbial%20Metabolites%20on%20Xanthine%20Oxidase%20Enzyme&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Mohos,%20Violetta&rft.date=2019-05-31&rft.volume=20&rft.issue=11&rft.spage=2681&rft.pages=2681-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms20112681&rft_dat=%3Cproquest_pubme%3E2235071069%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2249944192&rft_id=info:pmid/31159151&rfr_iscdi=true |